The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) includes a new classification called Disruptive Mood Dysregulation Disorder (DMDD). This diagnosis is intended for children previously misdiagnosed with ADHD or pediatric bipolar illness. Critics suggest the new category serves primarily to facilitate the marketing of new pharmaceutical treatments, such as Haldol, for pediatric use.
